Evidence map›Paper›PMID 15883164›Full record

ArticleThe Journal of biological chemistry2005

Interferon alpha activates NF-kappaB in JAK1-deficient cells through a TYK2-dependent pathway.

Chuan He Yang, Aruna Murti, William J Valentine, Ziyun Du, Lawrence M Pfeffer

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. The STAT3-Regulated Autophagy Pathway in Glioblastoma.Pharmaceuticals (Basel, Switzerland) · 2023
    Review
  4. IFNβ-InducedInternational journal of molecular sciences · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The role of nuclear factor κB in the interferon response.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2011
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Chuan He YangDepartment of Pathology and Laboratory Medicine, University of Tennessee Health Science Center and the University of Tennessee Cancer Institute, Memphis, Tennessee 38163, USA.
Aruna Murti
William J Valentine
Ziyun Du
Lawrence M Pfeffer
University of Tennessee Health Science Center · US

Funding

IFNARI SIGNALING THROUGH STAT3, PI 3 KINASER01CA073753 · NCI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI PFEFFER, LAWRENCE MARC · 1998 to 2007
$2.4M
NCI NIH HHS CA73753NCI NIH HHS R01 CA073753
6 · The paper itself

Abstract

In addition to activating members of the STAT transcription factor family, interferon alpha/beta (IFNalpha/beta) activates the NF-kappaB transcription factor. To determine the role of the Janus tyrosine kinase (JAK)-STAT pathway in NF-kappaB activation by IFN, we examined NF-kappaB activation in JAK1-deficient mutant human fibrosarcoma cells. In wild-type fibrosarcoma cells (2fTGH), IFN activates STAT1, STAT2, and STAT3, as well as NF-kappaB complexes comprised of p50 and p65. In contrast, in JAK1-deficient cells, IFN induces NF-kappaB activation and NF-kappaB dependent gene transcription but does not activate these STAT proteins and has no effect on STAT-dependent gene transcription. Expression of a catalytically inactive TYK2 tyrosine kinase in JAK1-deficient cells, as well as in the highly IFN-sensitive Daudi lymphoblastoid cell line, abrogates NF-kappaB activation by IFN. Moreover, IFN does not promote NF-kappaB activation in TYK2-deficient mutant fibrosarcoma cells. Our results demonstrate a dichotomy between the classical JAK-STAT pathway and the NF-kappaB signaling pathway. In the IFN signaling pathway leading to STAT activation, both JAK1 and TYK2 are essential, whereas NF-kappaB activation requires only TYK2.

Indexed as

Cell Line, TumorDNADNA-Binding ProteinsFibrosarcomaGene Expression RegulationGenes, ReporterHumansInterferon-alphaInterferon Regulatory Factor-1Janus Kinase 1LymphocytesNF-kappa BPhosphoproteinsProtein Serine-Threonine KinasesProtein-Tyrosine KinasesSignal TransductionDNADNA-Binding ProteinsInterferon-alphaInterferon Regulatory Factor-1IRF1 protein, humanJAK1 protein, humanJanus Kinase 1NF-kappa BPhosphoproteinsProtein Serine-Threonine KinasesProtein-Tyrosine KinasesSTAT3 protein, humanSTAT3 Transcription FactorTrans-ActivatorsTYK2 KinaseTYK2 protein, human

Identifiers

PMID15883164
PMCPMC1193649
OpenAlexW2161143698

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.